摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3,5-二-o-乙酰基-beta-d-呋喃核糖)-4-(1,2,4-噻唑-l-基)-5-甲基-2-嘧啶酮 | 80991-41-9

中文名称
1-(3,5-二-o-乙酰基-beta-d-呋喃核糖)-4-(1,2,4-噻唑-l-基)-5-甲基-2-嘧啶酮
中文别名
——
英文名称
1-(3,5-Di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)-5-methyl-4-(1,2,4-triazol-1-yl)-2(1H)-pyrimidinone
英文别名
4-(1,2,4-triazol-1-yl)-3',5'-di-O-acetyl-thymidine;1-(3,5-di-O-acetyl-β-D-2-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrimidin-2(1H)-one;5-methyl-4-(1,2,4-triazol-1-yl)-1-(β-D-3,5-di-O-acetyl-2-deoxyribofuranosyl)pyrimidin-2(1H)-one;4-(1,2,4-triazole-1-yl)-5-methyl-2-pyrimidon-1-yl-β-D-3',5'-di-O-acetyl-2'-deoxyribofuranoside;4-(1,2,4-triazol-1-yl)-5-methyl-2-pyrimidyn-1-yl-β-D-3',5'-di-O-acetyl-2' deoxyribofuranoside;1-(3,5-Di-O-acetyl-2-deoxy-beta-D-erythro-pentofuranosyl)-5-methyl-4-(1,2,4-triazol-1-yl)-2(1H)-pyrimidinone;[(2R,3S,5R)-3-acetyloxy-5-[5-methyl-2-oxo-4-(1,2,4-triazol-1-yl)pyrimidin-1-yl]oxolan-2-yl]methyl acetate
1-(3,5-二-o-乙酰基-beta-d-呋喃核糖)-4-(1,2,4-噻唑-l-基)-5-甲基-2-嘧啶酮化学式
CAS
80991-41-9
化学式
C16H19N5O6
mdl
——
分子量
377.357
InChiKey
CPXMZBUOUUNODF-BFHYXJOUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    578.1±60.0 °C(Predicted)
  • 密度:
    1.51±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    125
  • 氢给体数:
    0
  • 氢受体数:
    8

SDS

SDS:c75f7dd39cb1172f11b72411ed1cc2b1
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(3,5-二-o-乙酰基-beta-d-呋喃核糖)-4-(1,2,4-噻唑-l-基)-5-甲基-2-嘧啶酮ammonium hydroxide 作用下, 以 1,4-二氧六环 为溶剂, 以85%的产率得到5-甲基-2'-脱氧胞苷
    参考文献:
    名称:
    胸苷化学转化为5-甲基-2'-脱氧胞苷
    摘要:
    在氨水中,5-甲基-4-(1,2,4-三唑-1-基)-1-(β - D -3,5-二-O-乙酰基-2-脱氧核糖呋喃糖基)-嘧啶2(可以由胸苷制备的1 H)-一产生5-甲基-2'-脱氧胞苷。
    DOI:
    10.1039/c3981001089a
  • 作为产物:
    参考文献:
    名称:
    Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides
    摘要:
    One-pot syntheses provided a series of triazole- and pentafluorophenyloxy-substituted pyrimidine nucleosides. Most of the compounds in the series displayed anti-HIV activities but none as potent as AZT 2. 1-(beta-D-Erythro-pentofuranosyl)-4-pentafluorophenyloxy-2(1H)-pyr imidinone 14 was the most potent and the most selective compound in the series with EC50 = 1.6 microM.
    DOI:
    10.1016/s0014-827x(98)00107-4
点击查看最新优质反应信息

文献信息

  • Synthesis of Novel Nucleoside 5′-Triphosphates and Phosphoramidites Containing Alkyne or Amino Groups for the Postsynthetic Functionalization of Nucleic Acids
    作者:Svetlana V. Vasilyeva、Boris I. Budilkin、Dmitrii A. Konevetz、Vladimir N. Silnikov
    DOI:10.1080/15257770.2011.595379
    日期:2011.10
    phosphoramidites containing alkyne or amino groups for the postsynthetic functionalization of nucleic acids were designed and synthesized. For this purpose, the new 3-aminopropoxypropynyl linker group was used. It contains two alternative functional capabilities: an amino group for the reaction of amino–alkynyl-modified oligonucleotides with corresponding activated esters and an alkyne group for the copper(I)-catalyzed
    设计并合成了一系列新的含有炔或氨基的核苷5'-三磷酸和亚磷酰胺,用于核酸的后合成功能。为此,使用了新的3-氨基丙氧基丙炔基连接基团。它包含两种替代功能:用于氨基-炔基修饰的寡核苷酸与相应的活化酯反应的氨基和用于铜(I)催化的叠氮化物-炔烃环加成(CuAAC)反应的炔基。结果表明,可以使用多种连接新接头的方法来合成各种修饰的嘧啶核苷。
  • Solid-phase synthesis of oligodeoxynucleotides containing 4-alkoxythymidine residues
    作者:H. C. P. F. Roelen、H. F. Brugghe、H. van den Elst、G. A. van der Marel、J. H. van Boom
    DOI:10.1002/recl.19921110207
    日期:——
    Immobilized and fully protected oligodeoxynucleotides containing a 4-(1,2,4-triazolyl)-thymidine residue at a predetermined position were prepared according to a well-established phosphite triester methodology using 2-cyanoethyl phosphoramidites of a 4-(1,2,4-triazolyl)-substituted thymidine and standard protected nucleosides. Treatment of the immobilized oligomer with methanol, ethanol or n-propanol
    根据公认的亚磷酸酯三酯方法,使用4-(1,2,4-,1,2,3-三氟乙烷基)的2-氰基乙基亚磷酰胺,制备在预定位置上含有4-(1,2,4-三唑基)-胸苷残基的固定化和完全保护的寡脱氧核苷酸。 4-三唑基)-取代的胸苷和标准保护的核苷。在DBU存在下于50℃用甲醇,乙醇或正丙醇处理固定的低聚物,得到相应的含有4-甲氧基,4-乙氧基-或4-正丙氧基胸苷残基的寡核苷酸。
  • 5-Substituted <i>N</i><sup>4</sup>-Hydroxy-2‘-deoxycytidines and Their 5‘-Monophosphates:  Synthesis, Conformation, Interaction with Tumor Thymidylate Synthase, and in Vitro Antitumor Activity
    作者:Krzysztof Felczak、Agnieszka Miazga、Jarosław Poznański、Maria Bretner、Tadeusz Kulikowski、Jolanta M. Dzik、Barbara Gołos、Zbigniew Zieliński、Joanna Cieśla、Wojciech Rode
    DOI:10.1021/jm000975u
    日期:2000.11.1
    procedures are described for the synthesis of 5-substituted N(4)-hydroxy-2'-deoxycytidines 5a,b,d-h via transformation of the respective 5-substituted 3', 5'-di-O-acetyl-2'-deoxyuridines 1a-c,e-h. These procedures involved site-specific triazolation or N-methylimidazolation at position C(4), followed by hydroxylamination and deblocking with MeOH-NH(3). Nucleosides 5a,b,d-h were selectively converted
    描述了通过转化各自的5-取代的3',5'-二-O-乙酰基-2'-来合成5-取代的N(4)-羟基-2'-脱氧胞苷5a,b,dh的简便方法。脱氧尿苷1a-c,eh。这些程序包括在位置C(4)上进行位点特异性三唑基化或N-甲基咪唑基化,然后进行羟胺化并用MeOH-NH(3)进行解封。借助于麦芽磷酸转移酶系统,将核苷5a,b,dh选择性地转化为相应的5′-单磷酸酯6a,b,dh。由(1)H NMR光谱推导并通过分子力学计算证实的D(2)O溶液中每个核苷的构象表明,戊糖环主要存在于构象S(C-2'-endo)和N( 4)-OH基为顺式旋转异构体。研究了两种L5178Y鼠白血病细胞系对亲本和5-氟-2'-脱氧尿苷(FdUrd)的耐药性对细胞生长的抑制作用,后者对FdUrd的敏感性比前者低70倍。对于耐FdUrd的L5178Y细胞,5-氟-N(4)-羟基-2'-脱氧胞苷(5e)引起的生长抑制作用几乎是F
  • Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds
    作者:A. Stanley Jones、Jon R. Sayers、Richard T. Walker、Erik De Clercq
    DOI:10.1021/jm00396a043
    日期:1988.1
    Treatment of 3',5'-di-O-acetyl-(E)-5-(2-bromovinyl)-2'-deoxyuridine (2) with p-chlorophenyl phosphorodichloridate and 1,2,4-triazole gave 1-(3,5-di-O-acetyl-2-deoxy-beta-D-erythro-pentofuranosyl)-(E)-5-(2-br o movinyl)- 4-(1,2,4-triazol-1-yl)pyrimidin-2(1H)-one (3). Reaction of 3 with ammonia gave (E)-5-(2-bromovinyl)-2'-deoxycytidine (1), the overall yield from 2 being 60%. A similar 4-(1,2,4-triazol-1-yl)
    用对氯苯基二氯二氯和1,2,4-三唑处理3',5'-二-O-乙酰基-(E)-5-(2-溴乙烯基)-2'-脱氧尿苷(2)得到1-( 3,5-二-O-乙酰基-2-脱氧-β-D-赤型戊呋喃糖基)-(E)-5-(2-溴乙烯基)-4-(1,2,4-三唑-1- yl)嘧啶-2(1H)-一(3)。3与氨反应得到(E)-5-(2-溴乙烯基)-2′-脱氧胞苷(1),从2的总产率为60%。通过使用磷酰氯作为缩合剂,从3',5'-二-O-乙酰基胸苷获得相似的4-(1,2,4-三唑-1-基)衍生物(4)。用三甲基甲硅烷基氯,然后用磷酰氯和1,2,4-三唑处理胸腺嘧啶,在后处理中得到1-(2-脱氧-β-D-赤-戊呋喃糖基)-5-甲基-4(1,2,4-三唑-1-基)嘧啶2(1H)-一(5)。(E)-5-(2-溴乙烯基)-2' 脱氧尿苷(BVDU)经过类似处理后,得到相应的(E)-5-(2-溴乙烯基)化合物7。两种情况下形成的次要产物是4-(1
  • Reaction between nucleoside base residues and the phosphorylating agent derived from 1-hydroxybenzotriazole and 2-chloroprenyl phosphorodichloridate
    作者:Colin B. Reese、Keith H. Richards
    DOI:10.1016/s0040-4039(00)98973-1
    日期:1985.1
    In the presence of 1-methylimidazole, 2--acyl guanine (as in ), thymine (as in ) and uracil (as in ) residues react readily with the phosphorylating agent derived from 2-chlorophenyl phosphorodichloridate () and 1-hydroxybenzotriazole.
    在1-甲基咪唑,2-酰基鸟嘌呤(如),胸腺嘧啶(如)和尿嘧啶(如)的存在下,残基容易与衍生自2-氯苯基二氯磷酸酯()和1-羟基苯并三唑的磷酸化剂反应。
查看更多